Regentis Biomaterials RGNT
NYSE RGNT
$1.84 +0.03 (+1.65%)
As of: Oct 1, 2026 · 11:18 AM EDT

Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024)

Updated

Regentis Biomaterials (RGNT) posted Preferred Stock Liabilities of $35.1 million for Q4 2024.

Analysis

Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Regentis Biomaterials 1.05 Mn -7.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 35.10 Mn
API Access

Regentis Biomaterials Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=RGNT&period=max&api_key=YOUR_API_KEY